Medical diagnostics market: Growth Opportunities led by 3M Co. and Abbott Laboratories - Technavio
NEW YORK, Dec. 6, 2022 /PRNewswire/ -- The medical diagnostics market size is forecast to grow by USD 74.58 billion at a CAGR of 6.15% between 2022 and 2027. The growth of the market will be driven by the high prevalence of infectious diseases. Furthermore, the global adoption of advanced diagnostic solutions will foster the growth of the market.
The report extensively covers the medical diagnostics market segmentation by type (IVD and diagnostic imaging), end-user (hospitals and clinics, diagnostic centers, research laboratories and institutes, and others), and geography (North America, Asia, Europe, and the Rest of the World (ROW)).Request A Sample Report
Medical diagnostics market - Vendors
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.?
3M Co.
Agilent Technologies Inc.
Becton Dickinson & Co.
Bio-Rad Laboratories Inc.
bioMerieux SA
Charles River Laboratories
Danaher Corp.
DiaSorin SpA
F. Hoffmann La Roche Ltd.
General Electric Co.
Hologic Inc.
Medtronic Plc
QIAGEN NV
Quest Diagnostics Inc.
Quidel Corp.
Product Insights and News
3M Co.: The company offers medical diagnostics such as 3M Hydrophilic Films, 3M Substrates and Films, and 3M Adhesive, and Spacer Tapes.
Agilent Technologies Inc.: The company offers medical diagnostics such as HER2 IQFISH pharmDx, PD L1 IHC 22C3 pharmDx, and PD L1 IHC 28-8 pharmDx.
Bio-Rad Laboratories Inc.: The company offers medical diagnostics such as Blood Group Serology Testing, Hb Variants and Genetic Disorders, and Infectious Disease Testing.
bioMerieux SA: The company offers medical diagnostics such as Emag and biofire filmarray.
For detailed insights about product offerings and the growth strategies adopted by vendors, buy the report.
Medical diagnostics market - Geographical Landscape
Asia is estimated to contribute to 38% of the market growth by 2027. The growth of the regional market is driven by various factors such as rising healthcare expenditures, increased aging and chronic prevalent population, and growing trends toward POC, clinical chemistry and molecular diagnostic tools. Also, the growing prevalence of microsporidia infection in the geriatric population and the high preference toward technology-integrated medical diagnostics and POC devices are contributing to the growth of the medical diagnostics market in Asia.
Medical diagnostics market - MarketSegmentation
The IVD segment is estimated to contribute significantly to the global market's growth during the forecast period. The segment is driven by the growing importance of molecular, clinical, and immunoassay diagnostic techniques. Also, the increasing need for improved real-time diagnostic tools for the early diagnosis of communicable and chronic diseases is contributing to the growth of the segment. - Download a sample report
What are the key data covered in this medical diagnostics market report?
CAGR of the market during the forecast period.
Detailed information on factors that will drive the growth of the market between 2023 and 2027
Precise estimation of the medical diagnostics market size and its contribution to the parent market.
Accurate predictions about upcoming trends and changes in consumer behavior.
Growth of the industry across North America, Asia, Europe, and the Rest of the World (ROW).
Thorough analysis of the market's competitive landscape and detailed information about vendors.
Comprehensive analysis of factors that will challenge the growth of medical diagnostics market vendors.
The heart attack diagnostics market size is expected to increase by USD 5.34 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.51%. The rising prevalence of cardiac disorders is notably driving the heart attack diagnostics market growth, although factors such as pricing pressure among the vendors may impede the market growth.
The in-vitro diagnostics market is projected to grow by USD 33.16 billion with a CAGR of 6.89% during the forecast period 2021 to 2026. The increasing geriatric population with chronic and infectious diseases is one of the key drivers supporting the in-vitro diagnostics market growth.
Medical Diagnostics Market Scope
Report Coverage
Details
Page number
171
Base year
2022
Historic period
2017-2021
Forecast period
2023-2027
Growth momentum & CAGR
Accelerate at a CAGR of 6.15%
Market growth 2023-2027
USD 74.58 billion
Market structure
Fragmented
YoY growth 2022-2023 (%)
5.69
Regional analysis
North America, Asia, Europe, and Rest of World (ROW)
Performing market contribution
Asia at 38%
Key countries
US, China, Japan, Germany, and UK
Competitive landscape
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
3M Co., Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Charles River Laboratories, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., General Electric Co., Hologic Inc., Medtronic Plc, QIAGEN NV, Quest Diagnostics Inc., Quidel Corp., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc.
Market dynamics
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of contents:
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market by Geography
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Type
Exhibit 06: Executive Summary ? Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary ? Chart on Incremental Growth
Exhibit 08: Executive Summary ? Data Table on Incremental Growth
Exhibit 09: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global medical diagnostics market 2017 - 2021
Exhibit 18: Historic Market Size ? Data Table on Global medical diagnostics market 2017 - 2021 ($ billion)
Exhibit 54: Data Table on Diagnostic centers - Year-over-year growth 2022-2027 (%)
7.5 Research laboratories and institutes - Market size and forecast 2022-2027
Exhibit 55: Chart on Research laboratories and institutes - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Data Table on Research laboratories and institutes - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Chart on Research laboratories and institutes - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Research laboratories and institutes - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by End-user
Exhibit 63: Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 65: Chart on Market share by geography 2022-2027 (%)
Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Japan - Market size and forecast 2022-2027
Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 105: Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 108: Overview on factors of disruption
11.4 Industry risks
Exhibit 109: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 110: Vendors covered
12.2 Market positioning of vendors
Exhibit 111: Matrix on vendor position and classification
12.3 3M Co.
Exhibit 112: 3M Co. - Overview
Exhibit 113: 3M Co. - Business segments
Exhibit 114: 3M Co. - Key news
Exhibit 115: 3M Co. - Key offerings
Exhibit 116: 3M Co. - Segment focus
12.4 Abbott Laboratories
Exhibit 117: Abbott Laboratories - Overview
Exhibit 118: Abbott Laboratories - Business segments
Exhibit 119: Abbott Laboratories - Key news
Exhibit 120: Abbott Laboratories - Key offerings
Exhibit 121: Abbott Laboratories - Segment focus
12.5 Agilent Technologies Inc.
Exhibit 122: Agilent Technologies Inc. - Overview
Exhibit 123: Agilent Technologies Inc. - Business segments
Exhibit 124: Agilent Technologies Inc. - Key news
Exhibit 125: Agilent Technologies Inc. - Key offerings
Exhibit 126: Agilent Technologies Inc. - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 127: Bio Rad Laboratories Inc. - Overview
Exhibit 128: Bio Rad Laboratories Inc. - Business segments
Exhibit 129: Bio Rad Laboratories Inc. - Key news
Exhibit 130: Bio Rad Laboratories Inc. - Key offerings
Exhibit 131: Bio Rad Laboratories Inc. - Segment focus
12.7 bioMerieux SA
Exhibit 132: bioMerieux SA - Overview
Exhibit 133: bioMerieux SA - Product / Service
Exhibit 134: bioMerieux SA - Key offerings
12.8 Charles River Laboratories
Exhibit 135: Charles River Laboratories - Overview
Exhibit 136: Charles River Laboratories - Business segments
Exhibit 137: Charles River Laboratories - Key news
Exhibit 138: Charles River Laboratories - Key offerings
Exhibit 139: Charles River Laboratories - Segment focus
12.9 Danaher Corp.
Exhibit 140: Danaher Corp. - Overview
Exhibit 141: Danaher Corp. - Business segments
Exhibit 142: Danaher Corp. - Key news
Exhibit 143: Danaher Corp. - Key offerings
Exhibit 144: Danaher Corp. - Segment focus
12.10 DiaSorin SpA
Exhibit 145: DiaSorin SpA - Overview
Exhibit 146: DiaSorin SpA - Business segments
Exhibit 147: DiaSorin SpA - Key news
Exhibit 148: DiaSorin SpA - Key offerings
Exhibit 149: DiaSorin SpA - Segment focus
12.11 F. Hoffmann La Roche Ltd.
Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
12.12 General Electric Co.
Exhibit 155: General Electric Co. - Overview
Exhibit 156: General Electric Co. - Business segments
Exhibit 157: General Electric Co. - Key news
Exhibit 158: General Electric Co. - Key offerings
Exhibit 159: General Electric Co. - Segment focus
12.13 Hologic Inc.
Exhibit 160: Hologic Inc. - Overview
Exhibit 161: Hologic Inc. - Business segments
Exhibit 162: Hologic Inc. - Key news
Exhibit 163: Hologic Inc. - Key offerings
Exhibit 164: Hologic Inc. - Segment focus
12.14 QIAGEN NV
Exhibit 165: QIAGEN NV - Overview
Exhibit 166: QIAGEN NV - Product / Service
Exhibit 167: QIAGEN NV - Key news
Exhibit 168: QIAGEN NV - Key offerings
12.15 Quest Diagnostics Inc.
Exhibit 169: Quest Diagnostics Inc. - Overview
Exhibit 170: Quest Diagnostics Inc. - Business segments
Exhibit 171: Quest Diagnostics Inc. - Key offerings
Exhibit 172: Quest Diagnostics Inc. - Segment focus
12.16 Siemens AG
Exhibit 173: Siemens AG - Overview
Exhibit 174: Siemens AG - Business segments
Exhibit 175: Siemens AG - Key news
Exhibit 176: Siemens AG - Key offerings
Exhibit 177: Siemens AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 178: Thermo Fisher Scientific Inc. - Overview
Exhibit 179: Thermo Fisher Scientific Inc. - Business segments
Exhibit 180: Thermo Fisher Scientific Inc. - Key news
Exhibit 181: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 182: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 183: Inclusions checklist
Exhibit 184: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 185: Currency conversion rates for US$
13.4 Research methodology
Exhibit 186: Research methodology
Exhibit 187: Validation techniques employed for market sizing
Exhibit 188: Information sources
13.5 List of abbreviations
Exhibit 189: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024.
Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected]
Media contact:Atle Kigen, Head of...
Health Carousel, renowned for its dedication to enhancing the healthcare staffing sector, today unveiled its groundbreaking 'Full Circle of Support' program. This initiative represents a significant investment in the total well-being of its...
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...
Scottie Resources Corp. ("Scottie" or the "Company") announces that it has granted 7,400,000 options to acquire common shares to certain directors, officers, and consultants to the Company. The options are exercisable at a price of $0.195 per...
DaVita Inc. , announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
This call is...